+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 143 Pages
  • May 2023
  • Region: Global
  • IMARC Group
  • ID: 5820782
Description Jump to:
The global cancer/tumor profiling market size reached US$ 10.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 18.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.

Cancer/tumor profiling, also known as biomarker testing, refers to a laboratory test or procedure used to identify specific proteins, genes or gene mutations (changes) and other biomarkers in a tumor tissue sample. It assists oncologists in determining if the pathways of a patient’s tumor match up with the available targeted therapies. It also aids in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals based on the severity of their ailment and genomic build-up. Cancer/tumor profiling also finds extensive applications in personalized medicine, research, the discovery of biomarkers, and the development of screening and diagnostic techniques.

Cancer/Tumor Profiling Market Trends:

Cancer/tumor profiling is widely used in oncology research and discovery of biomarkers during the process of drug design, discovery and development. As a result, the widespread prevalence of cancer across the globe represents the primary factor driving the market growth. Besides this, the growing focus on biomarkers for diagnosis and tumor profiling and the shifting preferences toward personalized medicine among the masses are augmenting the product demand. Additionally, there has been a significant rise in government funding and support for cancer research for the development of advanced techniques to reduce the time taken for the detection and identification of tumors. Along with this, the recent advancements in molecular biology techniques, such as next-generation sequencing (NGS), are accelerating the adoption of cancer/tumor profiling. Furthermore, the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for the launch of novel therapies and new drug designing techniques are propelling the market growth. Other factors, including the rising number of clinical trials, growing adoption of immunoassay techniques, favorable reimbursement policies, improving healthcare infrastructure, and technological advancements, are also creating a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global cancer/tumor profiling market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cancer type, technology, technique and application.

Breakup by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others

Breakup by Technology:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In-Situ Hybridization (ISH)
  • Microarray
  • Others

Breakup by Technique:

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

Breakup by Application:

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Others

Breakup by Region:

North America

  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others

Latin America

  • Brazil
  • Mexico
  • Others

Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.

Key Questions Answered in This Report

1. What was the size of the global cancer/tumor profiling market in 2022?
2. What is the expected growth rate of the global cancer/tumor profiling market during 2023-2028?
3. What has been the impact of COVID-19 on the global cancer/tumor profiling market?
4. What are the key factors driving the global cancer/tumor profiling market?
5. What is the breakup of the global cancer/tumor profiling market based on the cancer type?
6. What is the breakup of the global cancer/tumor profiling market based on the technique?
7. What are the key regions in the global cancer/tumor profiling market?
8. Who are the key players/companies in the global cancer/tumor profiling market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer/Tumor Profiling Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Cancer Type
6.1 Breast Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Lung Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Colorectal Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Prostate Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Melanoma Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Technology
7.1 Next-Generation Sequencing (NGS)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymerase Chain Reaction (PCR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunohistochemistry (IHC)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 In-Situ Hybridization (ISH)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Microarray
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Technique
8.1 Genomics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Proteomics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Epigenetics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Metabolomics
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Application
9.1 Personalized Medicine
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Biomarker Discovery
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Prognostics
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Caris Life Sciences
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Exact Sciences Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 F. Hoffmann-La Roche Ltd
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Hologic Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 HTG Molecular Diagnostics Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Illumina Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Laboratory Corporation of America Holdings
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 NeoGenomics Laboratories
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Qiagen N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Siemens AG
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Sysmex Corporation
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Cancer/Tumor Profiling Market: Major Drivers and Challenges
Figure 2: Global: Cancer/Tumor Profiling Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer/Tumor Profiling Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer/Tumor Profiling Market: Breakup by Cancer Type (in %), 2022
Figure 5: Global: Cancer/Tumor Profiling Market: Breakup by Technology (in %), 2022
Figure 6: Global: Cancer/Tumor Profiling Market: Breakup by Technique (in %), 2022
Figure 7: Global: Cancer/Tumor Profiling Market: Breakup by Application (in %), 2022
Figure 8: Global: Cancer/Tumor Profiling Market: Breakup by Region (in %), 2022
Figure 9: Global: Cancer/Tumor Profiling (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cancer/Tumor Profiling (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cancer/Tumor Profiling (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cancer/Tumor Profiling (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cancer/Tumor Profiling (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cancer/Tumor Profiling (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cancer/Tumor Profiling (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cancer/Tumor Profiling (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cancer/Tumor Profiling (Microarray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cancer/Tumor Profiling (Microarray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cancer/Tumor Profiling (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cancer/Tumor Profiling (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Cancer/Tumor Profiling (Genomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Cancer/Tumor Profiling (Genomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Cancer/Tumor Profiling (Proteomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Cancer/Tumor Profiling (Proteomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Cancer/Tumor Profiling (Epigenetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Cancer/Tumor Profiling (Epigenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Cancer/Tumor Profiling (Metabolomics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Cancer/Tumor Profiling (Metabolomics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Cancer/Tumor Profiling (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Cancer/Tumor Profiling (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Cancer/Tumor Profiling (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Cancer/Tumor Profiling (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Cancer/Tumor Profiling (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Cancer/Tumor Profiling (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Cancer/Tumor Profiling (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Cancer/Tumor Profiling (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: North America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: North America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United States: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United States: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Canada: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Canada: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Asia-Pacific: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Asia-Pacific: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: China: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: China: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Japan: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Japan: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: India: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: India: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: South Korea: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: South Korea: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Australia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Australia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Indonesia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Indonesia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Europe: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Europe: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Germany: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Germany: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: France: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: France: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: United Kingdom: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: United Kingdom: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Italy: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Italy: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Spain: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Spain: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Russia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Russia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Latin America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Latin America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Brazil: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Brazil: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Mexico: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Mexico: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Middle East and Africa: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Middle East and Africa: Cancer/Tumor Profiling Market: Breakup by Country (in %), 2022
Figure 99: Middle East and Africa: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 100: Global: Cancer/Tumor Profiling Industry: SWOT Analysis
Figure 101: Global: Cancer/Tumor Profiling Industry: Value Chain Analysis
Figure 102: Global: Cancer/Tumor Profiling Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cancer/Tumor Profiling Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 3: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technique (in Million US$), 2023-2028
Table 5: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cancer/Tumor Profiling Market: Competitive Structure
Table 8: Global: Cancer/Tumor Profiling Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Caris Life Sciences
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc.
  • HTG Molecular Diagnostics Inc.
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories
  • Qiagen N.V.
  • Siemens AG and Sysmex Corporation.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages143
PublishedMay 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 10.4 Billion
Forecasted Market Value ( USD ) by 2028 $ 18.4 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Cancer Tumor Profiling Global Market Report 2024 - Product Image

Cancer Tumor Profiling Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Cancer / Tumor Profiling - Global Strategic Business Report - Product Image

Cancer / Tumor Profiling - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cancer Tumor Profiling Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Cancer Tumor Profiling Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 101 Pages
  • Global
From
2024 Global Forecast for the Cancer/Tumor Profiling Market (2025-2030 Outlook) - High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for the Cancer/Tumor Profiling Market (2025-2030 Outlook) - High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Diagnostic and Therapeutic Applications of Exosomes in Cancer - Product Image

Diagnostic and Therapeutic Applications of Exosomes in Cancer

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.